Prot #017004: An Open-Label, Phase 1 Safety and Phase 2 Randomized Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/18/191/18/25

Funding

  • DrugDev Inc. ((OE) Prot #017004 // (OE) Prot #017004)
  • Juno Therapeutics, Inc. ((OE) Prot #017004 // (OE) Prot #017004)